(Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity
Pathogenesis of AKI is complex and involves both local events in the kidney as well as systemic effects in the body that are interconnected and interdependent. Despite intensive investigations there is still no pharmacological agent that could provide complete protection against cisplatin nephrotoxi...
Main Authors: | Ž. Večerić-Haler, A. Cerar, M. Perše |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/7304643 |
Similar Items
-
Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges
by: Martina Perše, et al.
Published: (2018-01-01) -
Improved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte Globulin
by: Željka Večerić-Haler, et al.
Published: (2016-01-01) -
Early Graft Loss after Kidney Transplantation: Endothelial Dysfunction of Renal Microvasculature
by: N. Kojc, et al.
Published: (2018-01-01) -
The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
by: Tianbiao Zhou, et al.
Published: (2020-01-01) -
Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy
by: Željka Večerić-Haler, et al.
Published: (2021-07-01)